Antidepressant therapy in epilepsy: Can treating the comorbidities affect the underlying disorder?

British Journal of Pharmacology

Volumn 168, Issue 7, 2013, Pages 1531-1554

  Cardamone, L ^a   Salzberg, M R ^a,b   O'Brien, T J ^a   Jones, N C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b St Vincent's Mental Health Service   (Australia)

Author keywords

antidepressants; anxiety; depression; epilepsy; epileptogenesis; SSRI

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLOBAZAM; CLONAZEPAM; DESIPRAMINE; DESVENLAFAXINE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; SERTRALINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VIGABATRIN; ZONISAMIDE;

ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HEART DISEASE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; RESPIRATORY TRACT DISEASE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SEIZURE; SEPARATION ANXIETY; SUICIDE; TREATMENT RESPONSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; ANXIETY DISORDERS; BRAIN; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; EPILEPSY; HUMANS; SEIZURES; SEROTONIN UPTAKE INHIBITORS;

EID: 84875206814     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12052     Document Type: Review

References (337)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM, (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63: 642-649.
2. Adamec R, Shallow T, (2000). Rodent anxiety and kindling of the central amygdala and nucleus basalis. Physiol Behav 70: 177-187.
3. Adams SJ, O'Brien TJ, Lloyd J, Kilpatrick CJ, Salzberg MR, Velakoulis D, (2008). Neuropsychiatric morbidity in focal epilepsy. Br J Psychiatry 192: 464-469.
4. Adams SJ, Velakoulis D, Kaye AH, Corcoran NM, O'Brien TJ, (2012). Psychiatric history does not predict seizure outcome following temporal lobectomy for mesial temporal sclerosis. Epilepsia 53: 1700-1704.
5. Ago J, Ishikawa T, Matsumoto N, Ashequr Rahman M, Kamei C, (2006). Mechanism of imipramine-induced seizures in amygdala-kindled rats. Epilepsy Res 72: 1-9.
6. Ago J, Ishikawa T, Matsumoto N, Rahman MA, Kamei C, (2007). Epileptiformic activity induced by antidepressants in amygdala-kindled rats. Eur J Pharmacol 560: 23-28.
7. Ahern TH, Javors MA, Eagles DA, Martillotti J, Mitchell HA, Liles LC, et al,. (2006). The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology 31: 730-738.
8. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al,. (2005). Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90: 2522-2530.
9. Ali I, Salzberg MR, French C, Jones NC, (2011). Electrophysiological insights into the enduring effects of early life stress on the brain. Psychopharmacology (Berl) 214: 155-173.
10. Alper K, Schwartz KA, Kolts RL, Khan A, (2007). Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 62: 345-354.
11. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM, (2003). Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54: 703-709.
12. Altieri M, Marini F, Arban R, Vitulli G, Jansson BO, (2004). Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res 1000: 148-155.
13. Altman J, Das GD, (1965). Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124: 319-335.
14. Arai S, Morita K, Kitayama S, Kumagai K, Kumagai M, Kihira K, et al,. (2003). Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics. Brain Res 964: 83-90.
15. Asmussen SB, Kirlin KA, Gale SD, Chung SS, (2009). Differences in self-reported depressive symptoms between patients with epileptic and psychogenic nonepileptic seizures. Seizure 18: 564-566.
16. Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien LK, et al,. (2010). Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study. Epilepsy Behav 19: 467-473.
17. Asztely F, Kokaia M, Olofsdotter K, Ortegren U, Lindvall O, (2000). Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus. Eur J Neurosci 12: 662-669.
18. Auvin S, Porta N, Nehlig A, Lecointe C, Vallee L, Bordet R, (2009). Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res 86: 124-130.
19. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, et al,. (2006). Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 30: 1256-1260.
20. Aydemir O, Deveci A, Taneli F, (2005). The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29: 261-265.
21. Babb TL, (2001). Pathology of the temporal lobe: hippocampal sclerosis. In:, Luders HO, Comair YG, (eds). Epilepsy Surgery, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, PA, pp. 901-906.
22. Babu CS, Satishchandra P, Sinha S, Subbakrishna DK, (2009). Co-morbidities in people living with epilepsy: hospital based case-control study from a resource-poor setting. Epilepsy Res 86: 146-152.
23. Bagdy G, Kecskemeti V, Riba P, Jakus R, (2007). Serotonin and epilepsy. J Neurochem 100: 857-873.
24. Banerjee PN, Filippi D, Allen Hauser W, (2009). The descriptive epidemiology of epilepsy-a review. Epilepsy Res 85: 31-45.
25. Barden N, (1999). Regulation of corticosteroid receptor gene expression in depression and antidepressant action. J Psychiatry Neurosci 24: 25-39.
26. Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, et al,. (2008). Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 13 (Suppl. 1): S1-S29.
27. Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M, Lindvall O, (1997). Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 94: 10432-10437.
28. Berg AT, Scheffer IE, (2011). New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 52: 1058-1062.
29. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al,. (2010). Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51: 676-685.
30. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al,. (2009). The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14: 764-773, 739.
31. Blier P, de Montigny C, (1987). Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480.
32. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John Mann J, et al,. (2009). Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34: 2376-2389.
33. Bonelli SB, Powell R, Yogarajah M, Thompson PJ, Symms MR, Koepp MJ, et al,. (2009). Preoperative amygdala fMRI in temporal lobe epilepsy. Epilepsia 50: 217-227.
34. Bonnet U, (2003). Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 9: 97-140.
35. Borowicz KK, Stepien K, Czuczwar SJ, (2006). Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacol Rep 58: 83-90.
36. Borowicz KK, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar SJ, (2007). Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol 567: 77-82.
37. Borowicz KK, Golyska D, Luszczki JJ, Czuczwar SJ, (2011). Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol 670: 114-120.
38. Bouilleret V, Hogan RE, Velakoulis D, Salzberg MR, Wang L, Egan GF, et al,. (2009). Morphometric abnormalities and hyperanxiety in genetically epileptic rats: a model of psychiatric comorbidity? Neuroimage 45: 267-274.
39. Briellmann RS, Hopwood MJ, Jackson GD, (2007). Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry 78: 1226-1230.
40. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'anna M, Mascarenhas M, Escosteguy Vargas A, et al,. (2009). Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116: 214-217.
41. Browning RA, Wood AV, Merrill MA, Dailey JW, Jobe PC, (1997). Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol 336: 1-6.
42. Buckmaster PS, Zhang GF, Yamawaki R, (2002). Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. J Neurosci 22: 6650-6658.
43. Busch FN, Sandberg LS, (2012). Combined treatment of depression. Psychiatr Clin North Am 35: 165-179.
44. Castanon N, Bluthe RM, Dantzer R, (2001). Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl) 154: 50-60.
45. Castren E, Voikar V, Rantamaki T, (2007). Role of neurotrophic factors in depression. Curr Opin Pharmacol 7: 18-21.
46. Ceyhan M, Kayir H, Uzbay IT, (2005). Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. J Psychiatr Res 39: 191-196.
47. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT, (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50: 260-265.
48. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, (1999). Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291: 1-6.
49. Choi BH, Choi JS, Yoon SH, Rhie DJ, Min DS, Jo YH, et al,. (2001). Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology 41: 443-453.
50. Ciechanowski P, Chaytor N, Miller J, Fraser R, Russo J, Unutzer J, et al,. (2010). PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav 19: 225-231.
51. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y, (2004). Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology 47: 1053-1061.
52. Colman I, Ataullahjan A, (2010). Life course perspectives on the epidemiology of depression. Can J Psychiatry 55: 622-632.
53. Coppell AL, Pei Q, Zetterstrom TS, (2003). Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44: 903-910.
54. Corsellis JA, (1957). The incidence of Ammon's horn sclerosis. Brain 80: 193-208.
55. Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L, et al,. (2002). The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 51: 377-386.
56. Cotterman-Hart S, (2010). Depression in epilepsy: why aren't we treating? Epilepsy Behav 19: 419-421.
57. Cottrell GA, Nyakas C, de, Kloet ER, Bohus B, (1984). Hippocampal kindling: corticosterone modulation of induced seizures. Brain Res 309: 377-381.
58. Crespel A, Coubes P, Rousset MC, Brana C, Rougier A, Rondouin G, et al,. (2002). Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 952: 159-169.
59. Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, Lindsay RM, et al,. (1999). Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93: 1491-1506.
60. D'Sa C, Duman RS, (2002). Antidepressants and neuroplasticity. Bipolar Disord 4: 183-194.
61. Dailey JW, Jobe PC, (1986). Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia 27: 665-670.
62. Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC, (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 260: 533-540.
63. Deak F, Lasztoczi B, Pacher P, Petheo GL, Valeria K, Spat A, (2000). Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39: 1029-1036.
64. Desai SD, Shukla G, Goyal V, Singh S, Padma MV, Tripathi M, et al,. (2010). Study of DSM-IV Axis I psychiatric disorders in patients with refractory complex partial seizures using a short structured clinical interview. Epilepsy Behav 19: 301-305.
65. Dessain EC, Schatzberg AF, Woods BT, Cole JO, (1986). Maprotiline treatment in depression. A perspective on seizures. Arch Gen Psychiatry 43: 86-90.
66. Dias BG, Banerjee SB, Duman RS, Vaidya VA, (2003). Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45: 553-563.
67. Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ, (2005). Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57: 152-155.
68. Duman RS, Heninger GR, Nestler EJ, (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
69. Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ, (1999). Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res 838: 136-150.
70. Elmariah SB, Crumling MA, Parsons TD, Balice-Gordon RJ, (2004). Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J Neurosci 24: 2380-2393.
71. Elst LT, Groffmann M, Ebert D, Schulze-Bonhage A, (2009). Amygdala volume loss in patients with dysphoric disorder of epilepsy. Epilepsy Behav 16: 105-112.
72. Encinas JM, Vaahtokari A, Enikolopov G, (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 103: 8233-8238.
73. Engel J, Pedley T, (eds) (2007). Epilepsy: a Comprehensive Textbook. Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, PA.
74. Engel J, Pedley T, (2008). What Is Epilepsy? Lippincott Williams & Wilkins: Philadelphia, PA.
75. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al,. (1998). Neurogenesis in the adult human hippocampus. Nat Med 4: 1313-1317.
76. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O, (1991). Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7: 165-176.
77. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C, (1995). Anticonvulsant effect of fluoxetine in humans. Neurology 45: 1926-1927.
78. Favale E, Audenino D, Cocito L, Albano C, (2003). The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 12: 316-318.
79. FDA (2008). Statistical review and evaluation: antiepileptic drugs and suicidality. Available at: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008- 4372b1-01-FDA.pdf (accessed 2/25/2013).
80. Ferrero AJ, Cereseto M, Reines A, Bonavita CD, Sifonios LL, Rubio MC, et al,. (2005). Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: correlation with the hippocampal glutamate release. Prog Neuropsychopharmacol Biol Psychiatry 29: 678-686.
81. Filho GM, Rosa VP, Lin K, Caboclo LO, Sakamoto AC, Yacubian EM, (2008). Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav 13: 196-201.
82. Finegersh A, Avedissian C, Shamim S, Dustin I, Thompson PM, Theodore WH, (2011). Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures. Epilepsia 52: 689-697.
83. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al,. (2005). Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 470-472.
84. Foresti ML, Arisi GM, Katki K, Montanez A, Sanchez RM, Shapiro LA, (2009). Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J Neuroinflammation 6: 40.
85. Fornaro M, Martino M, Battaglia F, Colicchio S, Perugi G, (2011). Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. Neuropsychiatr Dis Treat 7: 51-56.
86. Forsgren L, Nystrom L, (1990). An incident case-referent study of epileptic seizures in adults. Epilepsy Res 6: 66-81.
87. Fountoulakis KN, Gonda X, Samara M, Siapera M, Karavelas V, Ristic DI, et al,. (2012). Antiepileptic drugs and suicidality. J Psychopharmacol 26: 1401-1407.
88. Friedman DE, Kung DH, Laowattana S, Kass JS, Hrachovy RA, Levin HS, (2009). Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure 18: 429-433.
89. Frisch C, Hanke J, Kleineruschkamp S, Roske S, Kaaden S, Elger CE, et al,. (2009). Positive correlation between the density of neuropeptide y positive neurons in the amygdala and parameters of self-reported anxiety and depression in mesiotemporal lobe epilepsy patients. Biol Psychiatry 66: 433-440.
90. Fuller-Thomson E, Brennenstuhl S, (2009). The association between depression and epilepsy in a nationally representative sample. Epilepsia 50: 1051-1058.
91. Furmaga H, Carreno FR, Frazer A, (2012). Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One 7: e34844.
92. Gaitatzis A, Carroll K, Majeed A, Sander JW, (2004). The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45: 1613-1622.
93. Gaitatzis A, Sisodiya SM, Sander JW, (2012). The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 53: 1282-1293.
94. Galic MA, Riazi K, Heida JG, Mouihate A, Fournier NM, Spencer SJ, et al,. (2008). Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 28: 6904-6913.
95. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ, (2009). Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36: 343-351.
96. Gallagher BB, (1987). Endocrine abnormalities in human temporal lobe epilepsy. Yale J Biol Med 60: 93-97.
97. Gallagher BB, Murvin A, Flanigin HF, King DW, Luney D, (1984). Pituitary and adrenal function in epileptic patients. Epilepsia 25: 683-689.
98. Gariboldi M, Tutka P, Samanin R, Vezzani A, (1996). Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br J Pharmacol 119: 813-818.
99. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, et al,. (2005). Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234-238.
100. Gigli GL, Diomedi M, Troisi A, Baldinetti F, Marciani MG, Girolami E, et al,. (1994). Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure 3: 221-224.
101. Gilby KL, Sydserff S, Patey AM, Thorne V, St-Onge V, Jans J, et al,. (2009). Postnatal epigenetic influences on seizure susceptibility in seizure-prone versus seizure-resistant rat strains. Behav Neurosci 123: 337-346.
102. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM, (2006). Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 5: 399-405.
103. Gilliam FG, Maton BM, Martin RC, Sawrie SM, Faught RE, Hugg JW, et al,. (2007). Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 68: 364-368.
104. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S, (2005). Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255: 381-386.
105. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, et al,. (2006). Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26: 11083-11110.
106. Groticke I, Hoffmann K, Loscher W, (2007). Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp Neurol 207: 329-349.
107. Groticke I, Hoffmann K, Loscher W, (2008). Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Exp Neurol 213: 71-83.
108. Hagan JJ, Hatcher JP, Slade PD, (1995). The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs. Eur J Pharmacol 294: 743-751.
109. Hannestad J, DellaGioia N, Bloch M, (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36: 2452-2459.
110. Harmant J, van Rijckevorsel-Harmant K, de Barsy T, Hendrickx B, (1990). Fluvoxamine: an antidepressant with low (or no) epileptogenic effect. Lancet 336: 386.
111. Hasler G, Bonwetsch R, Giovacchini G, Toczek MT, Bagic A, Luckenbaugh DA, et al,. (2007). 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62: 1258-1264.
112. Hattiangady B, Shetty AK, (2010). Decreased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy. Hippocampus 20: 97-112.
113. Hattiangady B, Rao MS, Shetty AK, (2004). Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol Dis 17: 473-490.
114. He XP, Kotloski R, Nef S, Luikart BW, Parada LF, McNamara JO, (2004). Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43: 31-42.
115. Hermann B, Jacoby A, (2009). The psychosocial impact of epilepsy in adults. Epilepsy Behav 15 (Suppl. 1): S11-S16.
116. Hermann B, Seidenberg M, Jones J, (2008). The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet Neurol 7: 151-160.
117. Hermann BP, Seidenberg M, Bell B, (2000). Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 41 (Suppl. 2): S31-S41.
118. Hernandez EJ, Williams PA, Dudek FE, (2002). Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43: 1337-1345.
119. Hesdorffer D, Krishnamoorthy E, (2011). Neuropsychiatric disorders in epilepsy: epidemiology and classification. In:, Trimble M, Schmitz B, (eds). Neuropsychiatric Disorders in Epilepsy: Epidemiology and Classification. Cambridge University Press: Cambridge, pp. 3-13.
120. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G, (2000). Major depression is a risk factor for seizures in older adults. Ann Neurol 47: 246-249.
121. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O, (2006). Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 59: 35-41.
122. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA, (2012). Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 72: 184-191.
123. Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, et al,. (2007). Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment. Neuropsychobiology 55: 28-35.
124. Hirvonen J, Kreisl WC, Fujita M, Dustin I, Khan O, Appel S, et al,. (2012). Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med 53: 234-240.
125. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ, (2007). Predictors of pharmacoresistant epilepsy. Epilepsy Res 75: 192-196.
126. Holsboer F, (2001). Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 62: 77-91.
127. Hoppe C, Elger CE, (2011). Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol 7: 462-472.
128. Hovorka J, Herman E, Nemcova II, (2000). Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 1: 444-447.
129. Igelstrom KM, (2012). Preclinical antiepileptic actions of selective serotonin reuptake inhibitors-implications for clinical trial design. Epilepsia 53: 596-605.
130. Igelstrom KM, Heyward PM, (2012). The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events. Epilepsy Res 101: 174-181.
131. Isbister GK, Bowe SJ, Dawson A, Whyte IM, (2004). Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42: 277-285.
132. Jaako K, Zharkovsky T, Zharkovsky A, (2009). Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus. Brain Res 1288: 18-28.
133. Jaako K, Aonurm-Helm A, Kalda A, Anier K, Zharkovsky T, Shastin D, et al,. (2011). Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus. Eur J Pharmacol 666: 61-71.
134. Jakubs K, Nanobashvili A, Bonde S, Ekdahl CT, Kokaia Z, Kokaia M, et al,. (2006). Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron 52: 1047-1059.
135. Janssen DG, Caniato RN, Verster JC, Baune BT, (2010). A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol 25: 201-215.
136. Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD, (1999). Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11: 465-471.
137. Jin Y, Lim CM, Kim SW, Park JY, Seo JS, Han PL, et al,. (2009). Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Brain Res 1281: 108-116.
138. Jobe PC, (2003). Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 4 (Suppl. 3): S14-S24.
139. Jobe PC, Browning RA, (2007). Animal models of depression and epilepsy: the genetically epilepsy-prone rat. In:, Ettinger AB, Kanner AM, (eds). Psychiatric Issues in Epilepsy. Lippincott W&W: Philadelphia, PA, pp. 38-48.
140. Jobe PC, Dailey JW, Wernicke JF, (1999). A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 13: 317-356.
141. Joels M, Baram TZ, (2009). The neuro-symphony of stress. Nat Rev Neurosci 10: 459-466.
142. Jones NC, Cardamone L, Williams JP, Salzberg MR, Myers D, O'Brien TJ, (2008a). Experimental traumatic brain injury induces a pervasive hyperanxious phenotype in rats. J Neurotrauma 25: 1367-1374.
143. Jones NC, Salzberg MR, Kumar G, Couper A, Morris MJ, O'Brien TJ, (2008b). Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol 209: 254-260.
144. Jones NC, Kumar G, O'Brien TJ, Morris MJ, Rees SM, Salzberg MR, (2009). Anxiolytic effects of rapid amygdala kindling, and the influence of early life experience in rats. Behav Brain Res 203: 81-87.
145. Jones NC, Martin S, Megatia I, Hakami T, Salzberg MR, Pinault D, et al,. (2010). A genetic epilepsy rat model displays endophenotypes of psychosis. Neurobiol Dis 39: 116-125.
146. Jongsma ME, Bosker FJ, Cremers TI, Westerink BH, den, Boer JA, (2005). The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog Neuropsychopharmacol Biol Psychiatry 29: 738-744.
147. Kabuto H, Yokoi I, Endo A, Takei M, Kurimoto T, Mori A, (1994a). Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity. Acta Med Okayama 48: 311-316.
148. Kabuto H, Yokoi I, Takei M, Kurimoto T, Mori A, (1994b). The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain. Neurochem Res 19: 463-467.
149. Kalynchuk LE, (2000). Long-term amygdala kindling in rats as a model for the study of interictal emotionality in temporal lobe epilepsy. Neurosci Biobehav Rev 24: 691-704.
150. Kanner AM, (2009). Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav 15: 83-87.
151. Kanner AM, (2011a). Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr 11: 90-91.
152. Kanner AM, (2011b). Depression and epilepsy: a bidirectional relation? Epilepsia 52 (Suppl. 1): 21-27.
153. Kanner AM, Balabanov A, (2002). Depression and epilepsy: how closely related are they? Neurology 58 (8 Suppl. 5): S27-S39.
154. Kanner AM, Kozak AM, Frey M, (2000). The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 1: 100-105.
155. Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M, (2009). A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 72: 793-799.
156. Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ, (2010). Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia 51: 1152-1158.
157. Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ, (2012). Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia 53: 1104-1108.
158. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM, (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148.
159. Karpova NN, Pickenhagen A, Lindholm J, Tiraboschi E, Kulesskaya N, Agustsdottir A, et al,. (2011). Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334: 1731-1734.
160. Karst H, de Kloet ER, Joels M, (1999). Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur J Neurosci 11: 889-898.
161. Kecskemeti V, Rusznak Z, Riba P, Pal B, Wagner R, Harasztosi C, et al,. (2005). Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull 67: 126-132.
162. Kelley MS, Jacobs MP, Lowenstein DH, (2009). The NINDS epilepsy research benchmarks. Epilepsia 50: 579-582.
163. Kenis G, Maes M, (2002). Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5: 401-412.
164. Kobayashi K, Ikeda Y, Sakai A, Yamasaki N, Haneda E, Miyakawa T, et al,. (2010). Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci U S A 107: 8434-8439.
165. Koe AS, Jones NC, Salzberg MR, (2009). Early life stress as an influence on limbic epilepsy: an hypothesis whose time has come? Front Behav Neurosci 3: 24.
166. Koella WP, Glatt A, Klebs K, Durst T, (1979). Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline. Biol Psychiatry 14: 485-497.
167. Koh S, Magid R, Chung H, Stine CD, Wilson DN, (2007). Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behav 10: 26-31.
168. Koyama R, Ikegaya Y, (2005). To BDNF or not to BDNF: that is the epileptic hippocampus. Neuroscientist 11: 282-287.
169. Koyama R, Yamada MK, Fujisawa S, Katoh-Semba R, Matsuki N, Ikegaya Y, (2004). Brain-derived neurotrophic factor induces hyperexcitable reentrant circuits in the dentate gyrus. J Neurosci 24: 7215-7224.
170. Krijzer F, Snelder M, Bradford D, (1984). Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Neuropsychobiology 12: 249-254.
171. Krishnan KR, (2007). Revisiting monoamine oxidase inhibitors. J Clin Psychiatry 68 (Suppl. 8): 35-41.
172. Kron MM, Zhang H, Parent JM, (2010). The developmental stage of dentate granule cells dictates their contribution to seizure-induced plasticity. J Neurosci 30: 2051-2059.
173. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al,. (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 (Suppl. 1): S71-S80.
174. Kuhn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE, (2003). Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4: 674-679.
175. Kumar G, Couper A, O'Brien TJ, Salzberg MR, Jones NC, Rees SM, et al,. (2007). The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 32: 834-842.
176. Kumar G, Jones NC, Morris MJ, Rees S, O'Brien TJ, Salzberg MR, (2011). Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights. Plos One 6: e24033.
177. Labate A, Cerasa A, Aguglia U, Mumoli L, Quattrone A, Gambardella A, (2011). Neocortical thinning in 'benign' mesial temporal lobe epilepsy. Epilepsia 52: 712-717.
178. Lacey CJ, Salzberg MR, Roberts H, Trauer T, D'Souza WJ, (2009). Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy. Epilepsia 50: 1991-1994.
179. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H, (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379.
180. Larmet Y, Reibel S, Carnahan J, Nawa H, Marescaux C, Depaulis A, (1995). Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6: 1937-1941.
181. Lee BH, Kim YK, (2010). The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig 7: 231-235.
182. Lee HM, Hahn SJ, Choi BH, (2010). Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin 31: 429-435.
183. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al,. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959-964.
184. Li Y, Luikart BW, Birnbaum S, Chen J, Kwon CH, Kernie SG, et al,. (2008). TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59: 399-412.
185. Lin JJ, Mula M, Hermann BP, (2012). Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 380: 1180-1192.
186. Lothe A, Didelot A, Hammers A, Costes N, Saoud M, Gilliam F, et al,. (2008). Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131 (Pt 10): 2765-2782.
187. Lu KT, Gean PW, (1998). Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 86: 729-737.
188. Luchins DJ, Oliver AP, Wyatt RJ, (1984). Seizures with antidepressants: an in vitro technique to assess relative risk. Epilepsia 25: 25-32.
189. Lupien SJ, McEwen BS, Gunnar MR, Heim C, (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10: 434-445.
190. McCloskey DP, Hintz TM, Pierce JP, Scharfman HE, (2006). Stereological methods reveal the robust size and stability of ectopic hilar granule cells after pilocarpine-induced status epilepticus in the adult rat. Eur J Neurosci 24: 2203-2210.
191. McLaughlin DP, Pachana NA, McFarland K, (2008). Depression in a community-dwelling sample of older adults with late-onset or lifetime epilepsy. Epilepsy Behav 12: 281-285.
192. Macrodimitris S, Wershler J, Hatfield M, Hamilton K, Backs-Dermott B, Mothersill K, et al,. (2011). Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav 20: 83-88.
193. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al,. (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34: 301-309.
194. Mainie I, McGurk C, McClintock G, Robinson J, (2001). Seizures after buproprion overdose. Lancet 357: 1624.
195. Malberg JE, Eisch AJ, Nestler EJ, Duman RS, (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110.
196. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, et al,. (2010). Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16: 413-419.
197. Mathern GW, Babb TL, Micevych PE, Blanco CE, Pretorius JK, (1997). Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol Chem Neuropathol 30: 53-76.
198. Mathern GW, Pretorius JK, Mendoza D, Lozada A, Kornblum HI, (1998). Hippocampal AMPA and NMDA mRNA levels correlate with aberrant fascia dentata mossy fiber sprouting in the pilocarpine model of spontaneous limbic epilepsy. J Neurosci Res 54: 734-753.
199. Mazarati A, Shin D, Auvin S, Caplan R, Sankar R, (2007). Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav 10: 377-383.
200. Mazarati A, Siddarth P, Baldwin RA, Shin D, Caplan R, Sankar R, (2008). Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 131 (Pt 8): 2071-2083.
201. Mazarati AM, Shin D, Kwon YS, Bragin A, Pineda E, Tio D, et al,. (2009). Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 34: 457-461.
202. Mazarati AM, Pineda E, Shin D, Tio D, Taylor AN, Sankar R, (2010). Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis 37: 461-467.
203. Mensah SA, Beavis JM, Thapar AK, Kerr MP, (2007). A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav 11: 118-124.
204. Mesquita AR, Tavares HB, Silva R, Sousa N, (2006). Febrile convulsions in developing rats induce a hyperanxious phenotype later in life. Epilepsy Behav 9: 401-406.
205. Metternich B, Wagner K, Brandt A, Kraemer R, Buschmann F, Zentner J, et al,. (2009). Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy. Epilepsy Behav 16: 622-628.
206. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M, (2001). Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11: 203-208.
207. Miller BH, Schultz LE, Gulati A, Cameron MD, Pletcher MT, (2008). Genetic regulation of behavioral and neuronal responses to fluoxetine. Neuropsychopharmacology 33: 1312-1322.
208. Minami M, Kuraishi Y, Satoh M, (1991). Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun 176: 593-598.
209. Mirescu C, Gould E, (2006). Stress and adult neurogenesis. Hippocampus 16: 233-238.
210. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G, (2002). Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43: 1148-1157.
211. Morgan VA, Croft ML, Valuri GM, Zubrick SR, Bower C, McNeil TF, et al,. (2012). Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression. Br J Psychiatry 200: 282-289.
212. Morimoto K, Fahnestock M, Racine RJ, (2004). Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73: 1-60.
213. Mula M, Monaco F, (2009a). Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 11: 1-9.
214. Mula M, Schmitz B, (2009b). Depression in epilepsy: mechanisms and therapeutic approach. Ther Adv Neurol Disord 2: 337-344.
215. Mula M, Schmitz B, Sander JW, (2008). The pharmacological treatment of depression in adults with epilepsy. Expert Opin Pharmacother 9: 3159-3168.
216. Mula M, Jauch R, Cavanna A, Gaus V, Kretz R, Collimedaglia L, et al,. (2010). Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia 51: 1139-1145.
217. Muller CJ, Bankstahl M, Groticke I, Loscher W, (2009a). Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage. Eur J Pharmacol 619: 15-24.
218. Muller CJ, Groticke I, Bankstahl M, Loscher W, (2009b). Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice. Exp Neurol 219: 284-297.
219. Murphy BL, Pun RY, Yin H, Faulkner CR, Loepke AW, Danzer SC, (2011). Heterogeneous integration of adult-generated granule cells into the epileptic brain. J Neurosci 31: 105-117.
220. Murray KD, Isackson PJ, Eskin TA, King MA, Montesinos SP, Abraham LA, et al,. (2000). Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy. J Comp Neurol 418: 411-422.
221. Najjar S, Bernbaum M, Lai G, Devinsky O, (2008). Immunology and epilepsy. Rev Neurol Dis 5: 109-116.
222. Nestler EJ, Hyman SE, Malenka RC, (2001). Molecular Neuropharmacology. McGraw Hill: New York.
223. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM, (2002). Neurobiology of depression. Neuron 34: 13-25.
224. Nibuya M, Morinobu S, Duman RS, (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
225. Nilsson FM, Kessing LV, Bolwig TG, (2003). On the increased risk of developing late-onset epilepsy for patients with major affective disorder. J Affect Disord 76: 39-48.
226. Niquet J, Ben-Ari Y, Represa A, (1994). Glial reaction after seizure induced hippocampal lesion: immunohistochemical characterization of proliferating glial cells. J Neurocytol 23: 641-656.
227. Noe KH, Locke DE, Sirven JI, (2011). Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 13: 371-379.
228. Okazaki M, Adachi N, Ito M, Watanabe M, Watanabe Y, Kato M, et al,. (2011). One-year seizure prognosis in epilepsy patients treated with antidepressants. Epilepsy Behav 22: 331-335.
229. Olsen RW, DeLorey TM, Gordey M, Kang MH, (1999). GABA receptor function and epilepsy. Adv Neurol 79: 499-510.
230. Osehobo P, Adams B, Sazgar M, Xu Y, Racine RJ, Fahnestock M, (1999). Brain-derived neurotrophic factor infusion delays amygdala and perforant path kindling without affecting paired-pulse measures of neuronal inhibition in adult rats. Neuroscience 92: 1367-1375.
231. Ottman R, Lipton RB, Ettinger AB, Cramer JA, Reed ML, Morrison A, et al,. (2011). Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 52: 308-315.
232. Owen BM, Eccleston D, Ferrier IN, Young AH, (2001). Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103: 226-228.
233. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C, 3rd, (1998). Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 284: 208-214.
234. Panelli RJ, Kilpatrick C, Moore SM, Matkovic Z, D'Souza WJ, O'Brien TJ, (2007). The Liverpool Adverse Events Profile: relation to AED use and mood. Epilepsia 48: 456-463.
235. Paparrigopoulos T, Ferentinos P, Brierley B, Shaw P, David AS, (2008). Relationship between post-operative depression/anxiety and hippocampal/amygdala volumes in temporal lobectomy for epilepsy. Epilepsy Res 81: 30-35.
236. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH, (1997). Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17: 3727-3738.
237. Parent JM, Elliott RC, Pleasure SJ, Barbaro NM, Lowenstein DH, (2006). Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann Neurol 59: 81-91.
238. Pariante CM, (2006). The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 20 (4 Suppl.): 79-84.
239. Pariante CM, Lightman SL, (2008). The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31: 464-468.
240. Parsons LH, Kerr TM, Tecott LH, (2001). 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77: 607-617.
241. Pasini A, Tortorella A, Gale K, (1992). Anticonvulsant effect of intranigral fluoxetine. Brain Res 593: 287-290.
242. Payandemehr B, Bahremand A, Rahimian R, Ziai P, Amouzegar A, Sharifzadeh M, et al,. (2012). 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide. Epilepsy Res 101: 217-227.
243. Pepin MC, Beaulieu S, Barden N, (1989). Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Brain Res Mol Brain Res 6: 77-83.
244. Pericic D, Lazic J, Svob Strac D, (2005). Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res 1033: 90-95.
245. Perr JV, Ettinger AB, (2011). Psychiatric illness and psychotropic medication use in epilepsy. In:, Trimble M, Schmitz B, (eds). The Neuropsychiatry of Epilepsy, Vol. 16. Cambridge University Press: Cambridge, pp. 165-195.
246. Petrovski S, Szoeke CE, Jones NC, Salzberg MR, Sheffield LJ, Huggins RM, et al,. (2010). Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 75: 1015-1021.
247. Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H, et al,. (2009). Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry 10: 313-323.
248. Pineda EA, Hensler JG, Sankar R, Shin D, Burke TF, Mazarati AM, (2012). Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurother 9: 477-485.
249. Pisani F, Spina E, Oteri G, (1999). Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40 (Suppl. 10): S48-S56.
250. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R, (2002). Effects of psychotropic drugs on seizure threshold. Drug Saf 25: 91-110.
251. Popoli M, Gennarelli M, Racagni G, (2002). Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord 4: 166-182.
252. Post RM, (2002). Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms? Epilepsy Res 50: 203-219.
253. Prendiville S, Gale K, (1993). Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 34: 381-384.
254. Preskorn SH, Fast GA, (1992). Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 53: 160-162.
255. Pritchard PB III, Wannamaker BB, Sagel J, Daniel CM, (1985). Serum prolactin and cortisol levels in evaluation of pseudoepileptic seizures. Ann Neurol 18: 87-89.
256. Raju SS, Noor AR, Gurthu S, Giriyappanavar CR, Acharya SB, Low HC, et al,. (1999). Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration. Pharmacol Res 39: 451-454.
257. Rao ML, Stefan H, Bauer J, (1989). Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 49: 33-39.
258. Reibel S, Larmet Y, Carnahan J, Marescaux C, Depaulis A, (2000a). Endogenous control of hippocampal epileptogenesis: a molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y. Epilepsia 41 (Suppl. 6): S127-S133.
259. Reibel S, Larmet Y, Le BT, Carnahan J, Marescaux C, Depaulis A, (2000b). Brain-derived neurotrophic factor delays hippocampal kindling in the rat. Neuroscience 100: 777-788.
260. Reul JM, Stec I, Soder M, Holsboer F, (1993). Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133: 312-320.
261. Reul JM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F, (1994). Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60: 509-519.
262. Richardson EJ, Griffith HR, Martin RC, Paige AL, Stewart CC, Jones J, et al,. (2007). Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 10: 242-249.
263. Richman A, Heinrichs SC, (2007). Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation. Epilepsy Res 74: 19-27.
264. Ridsdale L, Charlton J, Ashworth M, Richardson MP, Gulliford MC, (2011). Epilepsy mortality and risk factors for death in epilepsy: a population-based study. Br J Gen Pract 61: e271-e278.
265. Robertson MM, Trimble MR, Townsend HR, (1987). Phenomenology of depression in epilepsy. Epilepsia 28: 364-372.
266. Rudge JS, Mather PE, Pasnikowski EM, Cai N, Corcoran T, Acheson A, et al,. (1998). Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Exp Neurol 149: 398-410.
267. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW, (2000). Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101: 305-312.
268. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, et al,. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23: 349-357.
269. Salgado PC, Yasuda CL, Cendes F, (2010). Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression. Epilepsy Behav 19: 422-427.
270. Salzberg M, (2011). Neurobiological links between epilepsy and mood disorders. Neurology Asia 16: 37-40.
271. Salzberg M, Kumar G, Supit L, Jones NC, Morris MJ, Rees S, et al,. (2007). Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 48: 2079-2085.
272. Salzberg MR, Vajda FJ, (2001). Epilepsy, depression and antidepressant drugs. J Clin Neurosci 8: 209-215.
273. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al,. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
274. Santos JG Jr, Do Monte FH, Russi M, Agustine PE, Lanziotti VM, (2002). Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole- convulsive rats. Braz J Med Biol Res 35: 469-472.
275. Sarkisova K, van Luijtelaar G, (2011). The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected]. Prog Neuropsychopharmacol Biol Psychiatry 35: 854-876.
276. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M, (2000). Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A 97: 14731-14736.
277. Sayyah M, Javad-Pour M, Ghazi-Khansari M, (2003). The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience 122: 1073-1080.
278. Scharfman HE, (2007). The neurobiology of epilepsy. Curr Neurol Neurosci Rep 7: 348-354.
279. Scharfman H, Goodman J, McCloskey D, (2007). Ectopic granule cells of the rat dentate gyrus. Dev Neurosci 29: 14-27.
280. Scharfman HE, Goodman JH, Sollas AL, Croll SD, (2002). Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174: 201-214.
281. Schmitz B, (2011). The effects of antiepileptic drugs on behavior. In:, Trimble M, Schmitz B, (eds). The Neuropsychiatry of Epilepsy, 2nd edn. Cambridge University Press: Cambridge, pp. 133-142.
282. Settle EC, Stahl SM, Batey SR, Johnston JA, Ascher JA, (1999). Safety profile of sustained-release bupropion in depression: results of three clinical trials. Clin Ther 21: 454-463.
283. Shin RS, McIntyre DC, (2007). Differential noradrenergic influence on seizure expression in genetically Fast and Slow kindling rat strains during massed trial stimulation of the amygdala. Neuropharmacology 52: 321-332.
284. Shorvon SD, (2010). Handbook of Epilepsy Treatment. Wiley-Blackwell: Oxford.
285. Siegal J, Murphy GJ, (1979). Serotonergic inhibition of amygdala-kindled seizures in cats. Brain Res 147: 337-340.
286. Sloviter RS, (1994a). On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of humans and experimental animals. Hippocampus 4: 250-253.
287. Sloviter RS, (1994b). The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 35: 640-654.
288. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA, (2011). A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12: 585-601.
289. Song C, Zhang XY, Manku M, (2009). Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 29: 14-22.
290. Sorrells SF, Sapolsky RM, (2007). An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21: 259-272.
291. Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, et al,. (2004). Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27: 133-136.
292. Stahl S, (2008). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press: Cambridge.
293. Statnick M, Dailey J, Jobe P, Browning R, (1996). Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats. Eur J Pharmacol 299: 93-102.
294. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al,. (2007). Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007: 76396.
295. Taher TR, Salzberg M, Morris MJ, Rees S, O'Brien TJ, (2005). Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE. Neuropsychopharmacology 30: 1610-1616.
296. Takahashi M, Hayashi S, Kakita A, Wakabayashi K, Fukuda M, Kameyama S, et al,. (1999). Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y. Brain Res 818: 579-582.
297. Takeshita H, Kawahara R, Nagabuchi T, Mizukawa R, Hazama H, (1986). Serum prolactin, cortisol and growth hormone concentrations after various epileptic seizures. Jpn J Psychiatry Neurol 40: 617-623.
298. Tauck DL, Nadler JV, (1985). Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci 5: 1016-1022.
299. Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S, (2007). Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48: 2336-2344.
300. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, et al,. (2007). Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48: 1526-1530.
301. Thome-Souza MS, Kuczynski E, Valente KD, (2007). Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10: 417-425.
302. Thompson NJ, Walker ER, Obolensky N, Winning A, Barmon C, Diiorio C, et al,. (2010). Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT. Epilepsy Behav 19: 247-254.
303. Tiemeier H, Hofman A, van, Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM, (2003). Inflammatory proteins and depression in the elderly. Epidemiology 14: 103-107.
304. Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P, (2006). T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol 69: 1963-1968.
305. Trimble M, (1978). Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review. Epilepsia 19: 241-250.
306. Turrin NP, Rivest S, (2004). Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis 16: 321-334.
307. Tutka P, Barczynski B, Wielosz M, (2004). Convulsant and anticonvulsant effects of bupropion in mice. Eur J Pharmacol 499: 117-120.
308. Ugale RR, Mittal N, Hirani K, Chopde CT, (2004). Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res 1023: 102-111.
309. Vanpee D, Laloyaux P, Gillet JB, (1999). Seizure and hyponatraemia after overdose of trazadone. Am J Emerg Med 17: 430-431.
310. Velissaris SL, Wilson SJ, Newton MR, Berkovic SF, Saling MM, (2009). Cognitive complaints after a first seizure in adulthood: influence of psychological adjustment. Epilepsia 50: 1012-1021.
311. Vermoesen K, Serruys AS, Loyens E, Afrikanova T, Massie A, Schallier A, et al,. (2011). Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models. Epilepsy Behav 22: 450-460.
312. Vermoesen K, Massie A, Smolders I, Clinckers R, (2012). The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia 53: 870-878.
313. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al,. (2000). Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 97: 11534-11539.
314. Vezzani A, French J, Bartfai T, Baram TZ, (2011). The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
315. Vezzani A, Friedman A, Dingledine RJ, (2012). The role of inflammation in epileptogenesis. Neuropharmacology. doi: 10.1016/j.neuropharm.2012.04.004
316. Wada Y, Nakamura M, Hasegawa H, Shiraishi J, Yamaguchi N, (1993). Microinjection of the serotonin uptake inhibitor fluoxetine elevates hippocampal seizure threshold in rats. Neurosci Res Commun 13: 143-148.
317. Wada Y, Shiraishi J, Nakamura M, Hasegawa H, (1995). Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berl) 118: 305-309.
318. Wada Y, Shiraishi J, Nakamura M, Koshino Y, (1997). Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res 747: 338-342.
319. Wada Y, Hirao N, Shiraishi J, Nakamura M, Koshino Y, (1999). Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. Neurosci Lett 267: 61-64.
320. Walker ER, Obolensky N, Dini S, Thompson NJ, (2010). Formative and process evaluations of a cognitive-behavioral therapy and mindfulness intervention for people with epilepsy and depression. Epilepsy Behav 19: 239-246.
321. Wang GK, Mitchell J, Wang SY, (2008). Block of persistent late Na+ currents by antidepressant sertraline and paroxetine. J Membr Biol 222: 79-90.
322. Watanabe K, Ashby CR Jr, Katsumori H, Minabe Y, (2000). The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 398: 239-246.
323. Weiss G, Lucero K, Fernandez M, Karnaze D, Castillo N, (1993). The effect of adrenalectomy on the circadian variation in the rate of kindled seizure development. Brain Res 612: 354-356.
324. Wong M, (2010). Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 51: 27-36.
325. Wroblewski BA, McColgan K, Smith K, Whyte J, Singer WD, (1990). The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 10: 124-128.
326. Xu H, Steven Richardson J, Li XM, (2003). Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28: 53-62.
327. Xu JH, Long L, Tang YC, Zhang JT, Hut HT, Tang FR, (2009). CCR3, CCR2A and macrophage inflammatory protein (MIP)-1a, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE). Neuropathol Appl Neurobiol 35: 496-514.
328. Yan QS, Jobe PC, Dailey JW, (1993). Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Res 610: 24-31.
329. Yan QS, Jobe PC, Dailey JW, (1994). Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol 252: 105-112.
330. Yeung SY, Millar JA, Mathie A, (1999). Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 128: 1609-1615.
331. Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, et al,. (2001). Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24: 531-544.
332. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al,. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864.
333. Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, et al,. (2011). Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 31: 4037-4050.
334. Zhao C, Deng W, Gage FH, (2008). Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660.
335. Zhu WJ, Roper SN, (2001). Brain-derived neurotrophic factor enhances fast excitatory synaptic transmission in human epileptic dentate gyrus. Ann Neurol 50: 188-194.
336. Zienowicz M, Wislowska A, Lehner M, Taracha E, Skorzewska A, Maciejak P, et al,. (2005). The effect of fluoxetine in a model of chemically induced seizures-behavioral and immunocytochemical study. Neurosci Lett 373: 226-231.
337. Zobel A, Wellmer J, Schulze-Rauschenbach S, Pfeiffer U, Schnell S, Elger C, et al,. (2004). Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy. Eur Arch Psychiatry Clin Neurosci 254: 303-311.